What is a PVC?
A premature ventricular contraction (PVC) is an extra heartbeat that starts in the ventricles — the heart's lower pumping chambers — instead of the sinus node, the heart's natural pacemaker in the upper chambers. Because the beat fires early and travels through the heart muscle by an abnormal route, it looks wide and different on an ECG, and it often produces a distinctive sensation.[1]
Many people describe a PVC not as the early beat itself, but as what follows it: a brief pause (the heart “resetting”), then a forceful thump as the next normal beat pumps a chamber that had extra time to fill. Common descriptions include skipped beats, flip-flops, a fish flopping in the chest, or a sudden urge to cough.
PVCs are extremely common. They occur in most healthy people at some point, and occasional PVCs in a structurally normal heart are generally considered benign.[2] But “common” and “benign” are population statements — they say nothing about how disruptive PVCs can be for the individual who feels each one.
Burden vs. symptoms: the number isn't the whole story
“PVC burden” is the percentage (or daily count) of your heartbeats that are PVCs, usually measured with a 24-hour Holter or a multi-day wearable monitor. Burden matters clinically: research links very high burdens to a risk of weakened heart function over time (PVC-induced cardiomyopathy), which is a key reason treatment is recommended at high counts.[3]
The problem is what happens below those thresholds. Current decision-making often leans heavily on counts — figures like 10,000 PVCs per day are commonly cited — while symptom severity is underestimated.
Importantly, published guidelines do recognize symptoms: catheter ablation and medical therapy are established options for symptomatic PVCs even without high burden, when symptoms are significant and other causes are excluded.[4] In real-world practice, however, many highly symptomatic low-burden patients report being dismissed, attributed to anxiety, or told to simply live with it. That gap — between what guidelines allow and what patients experience — is why this platform exists.
Unifocal vs. multifocal PVCs
PVCs are also classified by where they come from:
| Type | What it means | Why it matters for treatment |
|---|---|---|
| Unifocal | All PVCs originate from a single spot in the ventricle. Every PVC looks identical on the ECG. | One target. If ablation is appropriate, the electrophysiologist maps and treats a single site — often with high success rates, especially for common origins like the right ventricular outflow tract.[5] |
| Multifocal | PVCs arise from two or more different locations. PVCs of different shapes (morphologies) appear on the ECG. | Multiple targets. Mapping is more complex, procedures are longer, and success may require addressing several sites — some of which may sit in difficult or risky locations. |
Multifocal cases are among the most challenging and debilitating forms of PVC-related conditions, yet they remain significantly under-addressed in clinical practice — particularly when one or more foci sit near critical conduction tissue.
Why location matters: the AV node, His bundle, and parahisian region
Catheter ablation works by delivering energy to the small area of heart muscle where a PVC originates. Success and safety depend heavily on where that area is. Some origins are routine; others sit millimeters from the heart's electrical wiring.
- The AV node is the electrical gateway between the upper and lower chambers.
- The His bundle is the cable that carries every normal impulse into the ventricles.
- Parahisian tissue is the region immediately surrounding the His bundle.
Ablating near these structures carries a real risk of damaging normal conduction — potentially causing heart block and the need for a permanent pacemaker.[6] Understandably, many electrophysiologists are hesitant to ablate in these regions, even when symptoms are severe. The result is a group of patients with genuinely difficult anatomy who may be declined for the one procedure that could help — and who often aren't told what emerging alternatives exist.
When medications fail
First-line medications for symptomatic PVCs typically include beta-blockers and calcium channel blockers; antiarrhythmic drugs such as flecainide or amiodarone may be considered in selected cases.[8] For many people these help. For many others, they don't — or the side effects (fatigue, brain fog, low blood pressure, exercise intolerance) trade one form of suffering for another.
If medications have failed you, that is not the end of the road, and it is not evidence that your symptoms aren't real. It is a recognized clinical scenario — drug-refractory symptomatic PVCs — and one of the standard indications for considering catheter ablation.[4] Patients in this situation deserve a clear conversation about all options, including referral to a high-volume center experienced with complex cases.
Common questions
Are PVCs dangerous?
In a structurally normal heart, occasional PVCs are generally considered benign. Very high burdens sustained over time can weaken heart function in some people, which is why monitoring matters. Anyone with PVCs plus fainting, sustained racing rhythms, a family history of sudden death, or known heart disease should be evaluated promptly. Only your own physician can assess your situation.[2]
Why do I feel every PVC when others feel none?
Symptom perception varies enormously between people and doesn't track neatly with burden. Factors like the timing of the PVC, the force of the following beat, body position, and individual sensitivity all play a role. Feeling your PVCs vividly is a real phenomenon — not a character flaw and not “just anxiety.”
My Holter says my burden is low. Why do I feel so terrible?
Burden measures how many PVCs you have, not how much they affect you. A low count of strongly felt PVCs — especially if they cluster during rest, sleep, or exercise — can be profoundly disruptive. This mismatch is exactly the gap PVC Voices advocates to close: symptom burden should carry equal weight to counts.
What should I ask my electrophysiologist?
Useful questions include: Are my PVCs unifocal or multifocal? Where do they originate? Am I a candidate for ablation, and if not, specifically why? What would change that answer? Are there high-volume centers or emerging technologies (such as pulse field ablation) relevant to my anatomy? What are the risks of treating — and of not treating?
Is this website medical advice?
No. PVC Voices is a patient-run educational and advocacy platform. Everything here is general information with sources you can verify — always discuss your specific situation with your physician or electrophysiologist.
You've got the basics. Now hear the voices.
Read stories from people who feel every beat — or explore the technologies that could change treatment for complex cases.
References
Numbered citations above link here. Final URLs to be inserted — suggested sources below are real, citable starting points for each claim.
- Definition and ECG characteristics of PVCs — e.g., Latchamsetty R, Bogun F. “Premature Ventricular Complexes and Premature Ventricular Complex–Induced Cardiomyopathy.” Circulation.
- Prevalence and prognosis in structurally normal hearts — e.g., large cohort/ambulatory ECG studies; AHA patient information on premature contractions.
- PVC burden and PVC-induced cardiomyopathy thresholds — e.g., Baman TS et al., “Relationship between burden of premature ventricular complexes and left ventricular function.” Heart Rhythm.
- Guideline indications for treating symptomatic PVCs — 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias; 2019 HRS/EHRA/APHRS/LAHRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias.
- Outflow-tract PVC ablation outcomes — published ablation success-rate series for RVOT PVCs.
- Risks of ablation near the His bundle / parahisian region — published case series on parahisian PVC ablation and heart-block risk.
- Pulse field ablation and advanced mapping — emerging literature on PFA selectivity for myocardium and early ventricular applications.
- Pharmacologic therapy for PVCs — beta-blockers, calcium channel blockers, antiarrhythmics per the 2017 AHA/ACC/HRS guideline.